Breaking News

Enzene Expands Biomanufacturing Operations at New Jersey Site

The extended plans include 26,000 square feet of drug substance manufacturing suites, laboratories, storage, dispensing, and warehousing.

By: Rachel Klemovitch

Assistant Editor

Enzene logo.

Enzene announced expanded plans for its biologics manufacturing facility in Hopewell, New Jersey.  This comes ahead of the official opening.  The site will now incorporate a further 26,000 square feet of drug substance manufacturing suites, laboratories, storage, dispensing, and warehousing. As well as conventional fed-batch drug substance manufacturing, the expanded scope of development will make extensive use of the modular EnzeneX 2.0 platform, which occupies a smaller footprint than th...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters